title: Nanotechnology: intelligent design to treat complex disease.
abstract: The purpose of this expert review is to discuss the impact of nanotechnology in the treatment of the major health threats including cancer, infections, metabolic diseases, autoimmune diseases, and inflammations. Indeed, during the past 30 years, the explosive growth of nanotechnology has burst into challenging innovations in pharmacology, the main input being the ability to perform temporal and spatial site-specific delivery. This has led to some marketed compounds through the last decade. Although the introduction of nanotechnology obviously permitted to step over numerous milestones toward the development of the "magic bullet" proposed a century ago by the immunologist Paul Ehrlich, there are, however, unresolved delivery problems to be still addressed. These scientific and technological locks are discussed along this review together with an analysis of the current situation concerning the industrial development.
authors.affiliation: Laboratoire de Physico-chimie, Pharmacotechnie et Biopharmacie, UMR CNRS 8612, Université de Paris Sud, 5 Rue J.B. Clément, 92 296, Chatenay-Malabry Cedex, France.
authors.forename: Patrick
authors.initials: P
authors.lastname: Couvreur
authors.forename: Christine
authors.initials: C
authors.lastname: Vauthier
mesh_terms: D000818:Animals; D000890:Anti-Infective Agents / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D016503:Drug Delivery Systems / Q000191:economics / Q000639:trends*; D004345:Drug Industry / Q000191:economics / Q000639:trends; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D036103:Nanotechnology / Q000191:economics / Q000639:trends*; D013678:Technology, Pharmaceutical / Q000191:economics / Q000639:trends
chemical_list: D000890:Anti-Infective Agents; D000970:Antineoplastic Agents; D007004:Hypoglycemic Agents